Investigational drug · Phase 2
CR-001
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Locally Advanced / Metastatic Solid Tumors.
Phase 2Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "CR-001"
First trial start
2026
Feb 17, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "CR-001", any sponsor or status.
Conditions studied
As listed on its trial records.
- Locally Advanced / Metastatic Solid Tumors
Approved drugs for the same conditions: Oncology
Largest trials
Live from ClinicalTrials.gov: studies naming "CR-001" as an intervention, largest first.
Crescent Biopharma, Inc.Industry
NCT07335497 · 540 participants (planned) · Start Feb 17, 2026 · Primary completion Feb 2029
Drug: CR-001; Paclitaxel and 8 more · For: Locally Advanced / Metastatic Solid Tumors
Sites: Birmingham, Alabama; Los Angeles, California; Denver, Colorado · 36 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- Phase I, open-label, multi-center dose-finding and expansion study to investigate the safety, tolerability, and preliminary efficacy of CR-001 (5-FU-miR-15a) in patients with acute myeloid leukemia.
Ktoridou-Valen I, Lenartova A, Grøndal SM, et al. · Leukemia 2026
- Direct Observation of Interfacial Exchange Coupling in a Magnetic Tunnel Junction through Spin-Polarized Quasiparticle Interference.
Wang X, Wang C, Yang Y, et al. · Nano Lett 2026
- Real-space observation of incommensurate spin density wave and coexisting charge density wave on Cr (001) surface.
Hu Y, Zhang T, Zhao D, et al. · Nat Commun 2022
- Fullerene/layered antiferromagnetic reconstructed spinterface: Subsurface layer dominates molecular orbitals' spin-split and large induced magnetic moment.
Shao Y, Pang R, Pan H, et al. · J Chem Phys 2018
- Electronic and magnetic structure of the Cr(001) surface.
Habibi P, Barreteau C, Smogunov A · J Phys Condens Matter 2013
- Large magnetoresistance through a single molecule due to a spin-split hybridized orbital.
Kawahara SL, Lagoute J, Repain V, et al. · Nano Lett 2012
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.